← Zuruck zu CVEs
CVE-2020-3909
CRITICAL9.8
Beschreibung
A buffer overflow was addressed with improved bounds checking. This issue is fixed in iOS 13.4 and iPadOS 13.4, macOS Catalina 10.15.4, tvOS 13.4, watchOS 6.2, iTunes for Windows 12.10.5, iCloud for Windows 10.9.3, iCloud for Windows 7.18. Multiple issues in libxml2.
CVE Details
CVSS v3.1 Bewertung9.8
SchweregradCRITICAL
CVSS VektorCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
AngriffsvektorNETWORK
KomplexitatLOW
Erforderliche PrivilegienNONE
BenutzerinteraktionNONE
Veroffentlicht4/1/2020
Zuletzt geandert11/21/2024
Quellenvd
Honeypot-Sichtungen0
Betroffene Produkte
apple:icloudapple:ipadosapple:iphone_osapple:itunesapple:mac_os_xapple:tvosapple:watchosoracle:sun_zfs_storage_appliance_kit_software
Schwachen (CWE)
CWE-120
Referenzen
https://support.apple.com/HT211100(product-security@apple.com)
https://support.apple.com/HT211101(product-security@apple.com)
https://support.apple.com/HT211102(product-security@apple.com)
https://support.apple.com/HT211103(product-security@apple.com)
https://support.apple.com/HT211105(product-security@apple.com)
https://support.apple.com/HT211106(product-security@apple.com)
https://support.apple.com/HT211107(product-security@apple.com)
https://www.oracle.com/security-alerts/cpuoct2020.html(product-security@apple.com)
https://support.apple.com/HT211100(af854a3a-2127-422b-91ae-364da2661108)
https://support.apple.com/HT211101(af854a3a-2127-422b-91ae-364da2661108)
https://support.apple.com/HT211102(af854a3a-2127-422b-91ae-364da2661108)
https://support.apple.com/HT211103(af854a3a-2127-422b-91ae-364da2661108)
https://support.apple.com/HT211105(af854a3a-2127-422b-91ae-364da2661108)
https://support.apple.com/HT211106(af854a3a-2127-422b-91ae-364da2661108)
https://support.apple.com/HT211107(af854a3a-2127-422b-91ae-364da2661108)
https://www.oracle.com/security-alerts/cpuoct2020.html(af854a3a-2127-422b-91ae-364da2661108)
IOC Korrelationen
Keine Korrelationen erfasst
This product uses data from the NVD API but is not endorsed or certified by the NVD.